{
    "Trade/Device Name(s)": [
        "Dimension Vista\u2122M System Drug 2 Calibrator",
        "DRUG 2 CAL - KC420",
        "Dimension Vista\u2122 Drug 2 Calibrator (KC420)"
    ],
    "Submitter Information": "Dade Behring Inc.",
    "510(k) Number": "K062121",
    "Predicate Device Reference 510(k) Number(s)": [
        "K033809"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "DKB"
    ],
    "Summary Letter Date": "July 24, 2006",
    "Summary Letter Received Date": "July 25, 2006",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21CFR862.3200"
    ],
    "Regulation Name(s)": [
        "Clinical Toxicology Calibrator"
    ],
    "Analyte Class(es)": [
        "tdm",
        "toxicology"
    ],
    "Analyte(s)": [
        "Acetaminophen",
        "Carbamazepine",
        "Digitoxin",
        "Gentamicin",
        "Lidocaine",
        "N-acetylprocainamide",
        "Procainamide",
        "Tobramycin",
        "Valproic acid",
        "Vancomycin"
    ],
    "Specimen Type(s)": [
        "Serum"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Dimension Vista\u2122 System"
    ],
    "Method(s)/Technology(ies)": [
        "Calibration"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Calibrator",
        "Kit"
    ],
    "Document Summary": "FDA 510(k) summary for Dimension Vista\u2122M System Drug 2 Calibrator for calibration of drug assays on Dimension Vista\u2122 System",
    "Indications for Use Summary": "In vitro diagnostic calibrator for acetaminophen, carbamazepine, digitoxin, gentamicin, lidocaine, N-acetylprocainamide, procainamide, tobramycin, valproic acid, and vancomycin methods on the Dimension Vista\u2122 System",
    "fda_folder": "Toxicology"
}